https://www.avient.com/sites/default/files/2024-11/AVNT M11 Investor Presentation_w_Non-GAAP.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Disruptions or inefficiencies in our supply chain, logistics, or operations;
• Changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Demand for our products and services;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
• Our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA;
• Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts and any recessionary conditions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2023 under Item 1A, “Risk Factors.”
When showing constant dollar figures on GAAP and non-GAAP financial measures, the foreign exchange impact is calculated by using current foreign exchange rates and applying them to the prior period results.
We also monitor earnings (defined as net income from continuing operations) before interest, taxes, depreciation
and amortization (EBITDA) and adjusted EBITDA (EBITDA before the impact of special items) as a supplement to our GAAP
measures.
https://www.avient.com/sites/default/files/resources/PolyOne%2520Proxy%2520Statement%25202016.pdf
Beneficial owners may vote in person at the meeting
if they have a legal proxy.
Since our
transformation began in 2006, our earnings per share has grown at a compounded annual growth rate of 36%.
We provide long-term incentive compensation to our Named Executive Officers to
directly tie the interests of these individuals to the interests of our shareholders.
https://www.avient.com/sites/default/files/2021-09/avient2020sustainabilityreport-9-2-21.pdf
Personal Values
Integrity.
They covered topics such as student loans, transitioning to the workplace, and
published interviews with senior leaders offering valuable career advice.
Message from the Governance and Corporate Responsibility Committee
Part of this metric was omitted due to availability (direct and clear discussion that community interests are stakeholder interests).
https://www.avient.com/company/sustainability/sustainability-report/people
To quantify risk and reduce it over time, Avient monitors several key performance indicators on a regular basis: Total Recordable Incident Rate (TRIR) and Lost Time Injury/Illness Rate (LTIR).
https://www.avient.com/products/polymer-additives/processing-enhancement-additives/cesa-plastone-processing-enhancing-additive
Cesa™ PlastOne™ concentrates can reduce cycle times, reduce scrap rates, and improve part aesthetics in injection molding and extrusion processes.
Reduced mold packing and hold times, lower injection and back pressures, and reduced scrap rates for shorter cycle times
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for Switzerland.pdf
Late payments will
bear interest at the maximum percent permitted by applicable law,
starting from the due date without further warning.
Buyer shall be obliged
to accept the Products and pay the rate specified in the order
confirmation for the quantity of Products delivered by Seller.
Seller
shall have the right to terminate an order confirmation with
immediate effect if at any time prior to delivery, a person or group
of persons who are unrelated to the persons controlling Buyer as of
the date of the order confirmation, acquires control, through
ownership of voting securities or otherwise, over Buyer.
https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for Austria.pdf
Late payments will
bear interest at the maximum percent permitted by applicable law
(Austrian Commercial Code - UGB).
Buyer shall be obliged
to accept the Products and pay the rate specified in the order
confirmation for the quantity of Products delivered by Seller.
Seller
shall have the right to terminate an order confirmation with
immediate effect if at any time prior to delivery, a person or group
of persons who are unrelated to the persons controlling Buyer as of
the date of the order confirmation, acquires control, through
ownership of voting securities or otherwise, over Buyer.
https://www.avient.com/investor-center/news/avient-expands-sustainable-solutions-portfolio-acquisition-magna-colours-ltd
We expect our collective inks portfolio will grow substantially as the threat of COVID subsides, people can safely attend sporting and other live events in person, and travel increases."
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired businesses into our operations, such as Magna Colours, retain the management teams of acquired businesses, and retain relationships with customers of acquired businesses; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; information systems failures and cyberattacks; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions.
https://www.avient.com/investor-center/news/avient-completes-acquisition-dsm-protective-materials-dyneema
The ultra-lightweight specialty fiber is 15 times stronger than steel and is used in demanding applications, such as ballistic personal protection, marine and sustainable infrastructure, renewable energy, industrial protection and outdoor sports.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; our ability to successfully integrate the Avient Protective Materials business and achieve the expected results of the business, including without limitation, the acquisition being accretive; any material adverse changes in the business supporting the Distribution assets being sold; the ability to obtain required regulatory approvals and otherwise consummate the proposed sale of the Distribution business; our ability to achieve the strategic and other objectives relating to the Avient Protective Materials business and the proposed sale of the Distribution business; and other factors described in our Annual Report on Form 10-K for the year ended
https://www.avient.com/news/medtec-china-2024-avient-announces-healthcare-tpu-manufacturing-expansion
Medical-grade pharmaceutical packaging solutions: oxygen scavenging additives, amber and white colorants, and white HDPE for MVTR (Moisture Vapor Transmission rate) reduction to protect drugs or nutraceuticals against UV light, moisture, and oxygen that cause product degradation.
Dyneema®, the world’s strongest fiber™, enables unmatched levels of performance and protection for end-use applications, including ballistic personal protection, marine and sustainable infrastructure and outdoor sports